National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)

National Health Commission of the People’s Republic of China

2022, 34(4): 309-334. doi: 10.21147/j.issn.1000-9604.2022.04.01

National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)

National Health Commission of the People’s Republic of China

2022, 34(4): 335-342. doi: 10.21147/j.issn.1000-9604.2022.04.02

Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer

Dan Lyu, Binliang Liu, Bo Lan, Xiaoying Sun, Lixi Li, Jingtong Zhai, Haili Qian, Fei Ma

2022, 34(4): 343-352. doi: 10.21147/j.issn.1000-9604.2022.04.03

Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer: A real-world, multicenter, retrospective, controlled study in China

Hanxiao Chen, Xiangjuan Ma, Jie Liu, Yu Yang, Yong Fang, Liping Wang, Jian Fang, Jun Zhao, Minglei Zhuo

2022, 34(4): 353-364. doi: 10.21147/j.issn.1000-9604.2022.04.04

Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer

Quan Jiang, Chenyu Tian, Hao Wu, Lingqiang Min, Hao Chen, Lingli Chen, Fenglin Liu, Yihong Sun

2022, 34(4): 365-382. doi: 10.21147/j.issn.1000-9604.2022.04.05

Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Changlong Li, Zhen Guan, Yi Zhao, Tingting Sun, Zhongwu Li, Weihu Wang, Zhexuan Li, Lin Wang, Aiwen Wu

2022, 34(4): 383-394. doi: 10.21147/j.issn.1000-9604.2022.04.06

Development and validation of a predictive model for endocervical curettage in patients referred for colposcopy: A multicenter retrospective diagnostic study in China

Peng Xue, Bingrui Wei, Samuel Seery, Qing Li, Zichen Ye, Yu Jiang, Youlin Qiao

2022, 34(4): 395-405. doi: 10.21147/j.issn.1000-9604.2022.04.07

Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study)

Shuangxi Li, Xiangji Ying, Fei Shan, Yongning Jia, Zhemin Li, Kan Xue, Rulin Miao, Yinkui Wang, Zhaode Bu, Xiangqian Su, Ziyu Li, Jiafu Ji

2022, 34(4): 406-414. doi: 10.21147/j.issn.1000-9604.2022.04.08

Clinical review considerations of class I PI3K inhibitors in hematolymphatic malignancies by Center for Drug Evaluation

Limin Zou, Yueli Qi, Ling Tang, Yu Du, Meiyi Xiang, Xiaoming Chen, Jun Ma, Zhimin Yang

2022, 34(4): 415-421. doi: 10.21147/j.issn.1000-9604.2022.04.09

Subpopulation cooperation renders drug resistance of hepatobiliary tumor organoids

Kuo Qi, Rong Liu

2022, 34(4): 422-424. doi: 10.21147/j.issn.1000-9604.2022.04.10